Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity
- PMID: 13679478
- DOI: 10.1093/ndt/gfg345
Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity
Abstract
Background: Studies of proliferative lupus nephritis (PLN) suggest that African-Americans have a poorer prognosis than Whites. However, no study has simultaneously examined socio-economic status. We studied rates of progression of PLN among a tri-ethnic population with respect to socio-economic status and race/ethnicity.
Methods: A retrospective cohort study was carried out using individual and census-based neighbourhood data. Consecutive patients in urban tertiary care centres with biopsy-proven PLN were studied. The main outcome was time to doubling of serum creatinine.
Results: Among 128 patients with PLN, the percentage of patients who did not double their serum creatinine at 5 years was 67.0% (+/-4.8%) and at 10 years was 58.9% (+/-5.7%). In bivariate analyses, residence in a poor neighbourhood was positively associated with progression (P = 0.03), as was African-American and Hispanic race/ethnicity (P = 0.01). Residence in a poor neighbourhood remained associated with progression of disease after adjustment for age, sex, creatinine, hypertension, cyclophosphamide treatment and race/ethnicity [relative risk (RR) 3.5, 95% confidence interval (CI) 1.2-11, P = 0.03]. After adjustment for poverty and insurance, the RR for African-American race/ethnicity was reduced from 3.5 to 2.7 and was not statistically associated with progression of disease in the full model (P = 0.10). A similar reduction in RR from 5.5 to 3.6 was seen for Hispanic race/ethnicity, but this retained statistical significance (P = 0.03).
Conclusions: Poverty is an important risk factor for progression of PLN, independent of race/ethnicity. Hispanics have an elevated risk similar to or greater than African-Americans. Given these findings, some of the poorer prognosis of African-American patients with PLN may result from socio-economic rather than biological or genetic factors.
Similar articles
-
Hospice usage by minorities in the last year of life: results from the National Mortality Followback Survey.J Am Geriatr Soc. 2003 Jul;51(7):970-8. doi: 10.1046/j.1365-2389.2003.51310.x. J Am Geriatr Soc. 2003. PMID: 12834517
-
Outcomes in African Americans and Hispanics with lupus nephritis.Kidney Int. 2006 May;69(10):1846-51. doi: 10.1038/sj.ki.5000243. Kidney Int. 2006. PMID: 16598205
-
Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA).Am J Hypertens. 2004 Oct;17(10):963-70. doi: 10.1016/j.amjhyper.2004.06.001. Am J Hypertens. 2004. PMID: 15485761
-
The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review.J Womens Health (Larchmt). 2009 Jun;18(6):883-93. doi: 10.1089/jwh.2008.1127. J Womens Health (Larchmt). 2009. PMID: 19514831 Review.
-
The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities.Clin Liver Dis. 2016 May;20(2):215-24. doi: 10.1016/j.cld.2015.10.005. Epub 2016 Feb 17. Clin Liver Dis. 2016. PMID: 27063265 Review.
Cited by
-
Unraveling Race, Socioeconomic Factors, and Geographical Context in the Heterogeneity of Lupus Mortality in the United States.ACR Open Rheumatol. 2019 Apr 29;1(3):164-172. doi: 10.1002/acr2.1024. eCollection 2019 May. ACR Open Rheumatol. 2019. PMID: 31777791 Free PMC article.
-
Treatment of proliferative lupus nephritis: a slowly changing landscape.Nat Rev Nephrol. 2011 Feb;7(2):96-109. doi: 10.1038/nrneph.2010.170. Epub 2010 Dec 21. Nat Rev Nephrol. 2011. PMID: 21173789 Review.
-
Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.Arthritis Rheum. 2012 Aug;64(8):2669-76. doi: 10.1002/art.34472. Arthritis Rheum. 2012. PMID: 22847366 Free PMC article.
-
Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics.Rheumatology (Oxford). 2025 Aug 1;64(8):4631-4640. doi: 10.1093/rheumatology/keaf205. Rheumatology (Oxford). 2025. PMID: 40221856 Free PMC article.
-
Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.Lupus. 2018 Nov;27(13):2146-2154. doi: 10.1177/0961203318804889. Epub 2018 Oct 14. Lupus. 2018. PMID: 30318995 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources